Human Papiloma Virus

Colombia Fails to Include HPV Vaccine in Public Health System

Author image

by Angela Castellanos, RH Reality Check, Latin America

January 13, 2009 - 8:00am (Print)

In Colombia, a bill that would introduce the vaccine into Bogotá's public health care system has just failed for the third time.
. . . . . . . . . .

Roundup: Abortion Has No Long-Term Effect on Mental Health; Allergic Reactions to Gardasil Uncommon

Author image

by Emily Douglas

December 4, 2008 - 11:14am (Print)

Abortion has no effect on long-term mental health; Clinton's likely priorities as Secretary of State; allergic reactions to Gardasil uncommon; what effect would HHS conscience regulations have?
. . . . . . . . . .

RH Reality Check Interviews Nobel Prizewinner Herald zur Hausen

Author image

by Lindsay Beyerstein, RH Reality Check

November 24, 2008 - 8:00am (Print)

Prof. Herald zur Hausen's Nobel Prize-winning research paved the way for the first vaccine against cancer in medical history, the HPV vaccine.
. . . . . . . . . .

Nobel Prize Awarded to Virologist Who Linked HPV to Cervical Cancer

Author image

by Lindsay Beyerstein, RH Reality Check

October 21, 2008 - 7:00am (Print)

German virologist Harold zur Hausen’s Nobel Prize is a reminder that there is overwhelming scientific consensus that HPV is the cause of cervical cancer.
. . . . . . . . . .

Inaccurate Pap Smear Results Common in Colombia

Author image

by Angela Castellanos, RH Reality Check, Latin America

October 1, 2008 - 7:00am (Print)

A majority of Colombian women get Pap smears, but new studies show that ten percent of such tests administered in Colombia yield inaccurate results.
. . . . . . . . . .

HPV Vaccine Access Should Be Unrestricted

Author image

by Alexa Stanard, New Journalist Fellow

February 25, 2008 - 8:46am (Print)

A new study has found that administering the HPV vaccine based on a woman's risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.

. . . . . . . . . .
Syndicate content